1. Home
  2. WGRX vs CALC Comparison

WGRX vs CALC Comparison

Compare WGRX & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wellgistics Health Inc.

WGRX

Wellgistics Health Inc.

HOLD

Current Price

$4.35

Market Cap

8.6M

Sector

Health Care

ML Signal

HOLD

Logo CalciMedica Inc.

CALC

CalciMedica Inc.

HOLD

Current Price

$1.07

Market Cap

9.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WGRX
CALC
Founded
2022
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Other Pharmaceuticals
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.6M
9.7M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
WGRX
CALC
Price
$4.35
$1.07
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$10.00
AVG Volume (30 Days)
43.9M
145.0K
Earning Date
05-21-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.30
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$2.84
Revenue Growth
N/A
N/A
52 Week Low
$0.07
$0.46
52 Week High
$4.49
$7.20

Technical Indicators

Market Signals
Indicator
WGRX
CALC
Relative Strength Index (RSI) 81.97 72.49
Support Level $0.26 $0.52
Resistance Level N/A $3.69
Average True Range (ATR) 0.43 0.10
MACD 0.31 0.03
Stochastic Oscillator 95.69 74.96

Price Performance

Historical Comparison
WGRX
CALC

About WGRX Wellgistics Health Inc.

Wellgistics Health Inc is a healthcare technology and pharmaceutical logistics company. It simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. The company seeks to be a micro health ecosystem, with a portfolio comprising a pharmacy, wholesale operations, and a technology division that provides a novel platform for hub and clinical services. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys. The company operates as one operating segment focused on developing and commercializing therapeutics in the U.S.

Share on Social Networks: